The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries
Estimates the potential economic impact of introducing novel TB vaccines in 105 low- and middle- income countries. It compares ifnant and adolescents/ adult vaccination scenarios and models their effects on TB- related mortality, morbidity, healthcare costs and GDP. Finding support decision making on the future development and introduciton of novel TB vaccines
TB vaccine theme
Project details
Country
Afghanistan, Albania, Angola, Argentina, Armenia, Azerbaijan, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic, Chad, China, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Fiji, Gabon, Gambia, Georgia, Ghana, Guatemala, Guinea, Honduras, India, Indonesia, Iran, Iraq, Ivory Coast, Jordan, Kazakhstan, Kenya, Kyrgyzstan, Laos, Lesotho, Liberia, Libya, Madagascar, Malawi, Malaysia, Maldives, Mali, Mauritania, Mauritius, Mexico, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Palau, Papua New Guinea, Paraguay, Peru, Philippines, Russia, Rwanda, São Tomé and Principe, Senegal, Serbia, Sierra Leone, Solomon Islands, South Africa, South Sudan, Sri Lanka, Sudan, Suriname, Swaziland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tunisia, Turkey, Uganda, Ukraine, Uzbekistan, Vanuatu, Vietnam, Yemen, Zambia, Zimbabwe
Timeline
Target group
Vaccine
Type of protection of vaccine
Type of research
Partners involved
BMGF, Boston University School of Public Health, Canadian Centennial Scholarship Fund, CEPI, EDCTP, Fondation pour les études et recherches sur le développement international, Global Development Network, Graduate Institute of International and Development Studies, Harvard T.H. Chan School of Public Health, KNCV, LSHTM, NIH, UK Research & Innovation Economic and Social Research Council, UK Research & Innovation Medical Research Council, Université Mohammed VI Polytechnique, University of Hong Kong, Wellcome trust, WHO